Abstract

Public Health Relevance

Aggressive surgical resection followed by adjuvant therapy consisting of (chemo)radiation is the mainstay of treatment for squamous cell carcinoma of the head and neck (SCCHN). Despite these treatments, SCCHN is a devastating disease that portends an overall 5-year survival of only ~50%. There is therefore a need to identify novel strategies and drug combinations to treat SCCHN.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE028343-01
Application #
9638657
Study Section
Basic Mechanisms of Cancer Therapeutics Study Section (BMCT)
Program Officer
Wang, Chiayeng
Project Start
2019-01-01
Project End
2023-12-31
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost

  Institution

Name
University of Pittsburgh
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15260